why choose us

First received: August 17, 2022

Clinical Trial: Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Hematopoietic and Lymphoid System Neoplasm

Study Type: INTERVENTIONAL


Official Title: Pilot Study of Safety and Feasibility of Electron Beam Radiotherapy to Treat Refractory Sclerodermatous Chronic Graft-versus-Host Disease

Brief Summary: This clinical trial tests the safety and side effects of a single small dose (fraction) of electron beam radiotherapy (e-BRT) at 10 Gy dose in treating patients with refractory (did not respond to other treatments) sclerodermatous chronic graft versus host disease (GVHD).GVHD is the most common complication after bone marrow transplant from a donor and happens as a result of donor immune cells attacking patients cells.Fibroblasts are skin cells that produce collagen and fibers and are the cells mainly involved in…

Read more